Literature DB >> 20063077

Thermal stability investigation and the kinetic study of Folnak degradation process under nonisothermal conditions.

Bojan Jankovi1.   

Abstract

The nonisothermal degradation process of Folnak drug samples was investigated by simultaneous thermogravimetric and differential thermal analysis in the temperature range from an ambient one up to 810 degrees C. It was established that the degradation proceeds through the five degradation stages (designated as I, II, III, IV, and V), which include: the dehydration (I), the melting process of excipients (II), as well as the decomposition of folic acid (III), corn starch (IV), and saccharose (V), respectively. It was established that the presented excipients show a different behavior from that of the pure materials. During degradation, all excipients increase their thermal stability, and some kind of solid-solid and/or solid-gas interaction occurs. The kinetic parameters and reaction mechanism for the folic acid decomposition were established using different calculation procedures. It was concluded that the folic acid decomposition mechanism cannot be explained by the simple reaction order (ROn) model (n = 1) but with the complex reaction mechanism which includes the higher reaction orders (RO, n > 1), with average value of <n > = 1.91. The isothermal predictions of the third (III) degradation stage of Folnak sample, at four different temperatures (T (iso) = 180 degrees C, 200 degrees C, 220 degrees C, and 260 degrees C), were established. It was concluded that the shapes of the isothermal conversion curves at lower temperatures (180-200 degrees C) were similar, whereas became more complex with further temperature increase due to the pterin and p-amino benzoic acid decomposition behavior, which brings the additional complexity in the overall folic acid decomposition process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20063077      PMCID: PMC2850477          DOI: 10.1208/s12249-009-9363-6

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  8 in total

1.  The history of folic acid.

Authors:  A V Hoffbrand; D G Weir
Journal:  Br J Haematol       Date:  2001-06       Impact factor: 6.998

Review 2.  Basics and applications of solid-state kinetics: a pharmaceutical perspective.

Authors:  Ammar Khawam; Douglas R Flanagan
Journal:  J Pharm Sci       Date:  2006-03       Impact factor: 3.534

3.  Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry, hot-stage microscopy and scanning electron microscopy.

Authors:  P Mura; M T Faucci; A Manderioli; G Bramanti; L Ceccarelli
Journal:  J Pharm Biomed Anal       Date:  1998-10       Impact factor: 3.935

4.  Clinico-hematological profile of megaloblastic anemia.

Authors:  S Gomber; K Kela; N Dhingra
Journal:  Indian Pediatr       Date:  1998-01       Impact factor: 1.411

5.  Initiation of protein synthesis by folate-sufficient and folate-deficient Streptococcus faecalis R. Biochemical and biophysical properties of methionine transfer ribonucleic acid.

Authors:  C E Samuel; J C Rabinowitz
Journal:  J Biol Chem       Date:  1974-02-25       Impact factor: 5.157

Review 6.  The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility.

Authors:  I M W Ebisch; C M G Thomas; W H M Peters; D D M Braat; R P M Steegers-Theunissen
Journal:  Hum Reprod Update       Date:  2006-11-11       Impact factor: 15.610

7.  Thermal analysis of the antiretroviral zidovudine (AZT) and evaluation of the compatibility with excipients used in solid dosage forms.

Authors:  Adriano A S Araújo; Sílvia Storpirtis; Lucildes P Mercuri; Flávio M S Carvalho; Mery dos Santos Filho; Jivaldo R Matos
Journal:  Int J Pharm       Date:  2003-07-24       Impact factor: 5.875

8.  Homocystinuria: a rare cause of megaloblastic anemia.

Authors:  Sunil Gomber; Pooja Dewan; Tarun Dua
Journal:  Indian Pediatr       Date:  2004-09       Impact factor: 1.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.